← All comparisons
Head-to-head · FAERS comparison

Clopidogrel vs Warfarin: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

ClopidogrelWarfarin
Drug class––
Brand names–Warfarin Sodium
FAERS reports197,000126,271
Serious81%80%
Death outcome21,77916,103
Boxed warningYes DIMINISHED EFFECTIVENESS IN POOR METABOLIZERS The effectiveness of clopidogrel is dependent on its activation to an active metabolite by the cytochrome P450 (CYYes BLEEDING RISK Warfarin sodium can cause major or fatal bleeding [see Warnings and Precautions (5.1) ] . Perform regular monitoring of INR in all treated patient

Signals both drugs share

ReactionClopidogrelWarfarinLabel screen (A / B)
Retroperitoneal haemorrhage253 · PRR 12.0261 · PRR 19.5Labeled adverse reaction / Not in label — unassessed
Retroperitoneal haematoma229 · PRR 12.3268 · PRR 23.0Labeled (related wording) / Not in label — unassessed
Spinal epidural haematoma123 · PRR 29.586 · PRR 29.7Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Clopidogrel

Labeled signals distinctive to Warfarin

Common questions

Which has more reported side effects, Clopidogrel or Warfarin?

Clopidogrel has 197,000 FAERS reports and Warfarin 126,271. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (81% vs 80%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Clopidogrel and Warfarin share?

Both drugs carry disproportionality signals for retroperitoneal haemorrhage, retroperitoneal haematoma, spinal epidural haematoma. Shared signals often reflect a shared drug class or the condition both are used for.

Is Clopidogrel or Warfarin safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.